Folgen
Andreas Roller
Andreas Roller
Roche Pharma Research and Early Development (pRED)
Bestätigte E-Mail-Adresse bei roche.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, ...
Leukemia 28 (2), 241-247, 2014
16432014
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ...
Nature medicine 24 (7), 994-1004, 2018
8672018
MicroRNA loss enhances learning and memory in mice
W Konopka, A Kiryk, M Novak, M Herwerth, JR Parkitna, M Wawrzyniak, ...
Journal of Neuroscience 30 (44), 14835-14842, 2010
3662010
Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors
DS Thommen, J Schreiner, P Müller, P Herzig, A Roller, A Belousov, ...
Cancer immunology research 3 (12), 1344-1355, 2015
3632015
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
M Meggendorfer, A Roller, T Haferlach, C Eder, F Dicker, V Grossmann, ...
Blood, The Journal of the American Society of Hematology 120 (15), 3080-3088, 2012
3342012
A novel hierarchical prognostic model of AML solely based on molecular mutations
V Grossmann, S Schnittger, A Kohlmann, C Eder, A Roller, F Dicker, ...
Blood, The Journal of the American Society of Hematology 120 (15), 2963-2972, 2012
3142012
Landscape of TET2 mutations in acute myeloid leukemia
S Weissmann, T Alpermann, V Grossmann, A Kowarsch, N Nadarajah, ...
Leukemia 26 (5), 934-942, 2012
3042012
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
S Jeromin, S Weissmann, C Haferlach, F Dicker, K Bayer, V Grossmann, ...
Leukemia 28 (1), 108-117, 2014
2972014
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes
A Ruepp, A Kowarsch, D Schmidl, F Buggenthin, B Brauner, I Dunger, ...
Genome biology 11, 1-11, 2010
2972010
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
M Mayoux, A Roller, V Pulko, S Sammicheli, S Chen, E Sum, C Jost, ...
Science translational medicine 12 (534), eaav7431, 2020
2772020
The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL
V Grossmann, C Haferlach, S Weissmann, A Roller, S Schindela, ...
Genes, Chromosomes and Cancer 52 (4), 410-422, 2013
1882013
Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
S Soverini, C De Benedittis, K Machova Polakova, A Brouckova, D Horner, ...
Blood, The Journal of the American Society of Hematology 122 (9), 1634-1648, 2013
1812013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
A Kohlmann, N Nadarajah, T Alpermann, V Grossmann, S Schindela, ...
Leukemia 28 (1), 129-137, 2014
1262014
Landmark analysis of DNMT3A mutations in hematological malignancies
A Roller, V Grossmann, U Bacher, F Poetzinger, S Weissmann, ...
Leukemia 27 (7), 1573-1578, 2013
1022013
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation
TC Jungraithmayr, K Hofer, P Cochat, G Chernin, G Cortina, S Fargue, ...
Journal of the American Society of Nephrology 22 (3), 579-585, 2011
982011
Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier
B Balluff, M Elsner, A Kowarsch, S Rauser, S Meding, C Schuhmacher, ...
Journal of proteome research 9 (12), 6317-6322, 2010
882010
Hypothalamic miR-103 protects from hyperphagic obesity in mice
IA Vinnikov, K Hajdukiewicz, J Reymann, J Beneke, R Czajkowski, ...
Journal of Neuroscience 34 (32), 10659-10674, 2014
872014
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients
S Weissmann, A Roller, S Jeromin, M Hernandez, M Abaigar, ...
Leukemia 27 (12), 2393-2396, 2013
872013
Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets
V Raia, M Schilling, M Böhm, B Hahn, A Kowarsch, A Raue, C Sticht, ...
Cancer research 71 (3), 693-704, 2011
852011
Correlated mutations: a hallmark of phenotypic amino acid substitutions
A Kowarsch, A Fuchs, D Frishman, P Pagel
PLoS computational biology 6 (9), e1000923, 2010
802010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20